SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chadi Nabhan, Sonali M. Smith, Irene Helenowski, Erika Ramsdale, Benjamin Parsons, Reem Karmali, Josephine Feliciano, Britt Hanson, Scott Smith, June McKoy, Annette Larsen, Andrew Hantel, Stephanie Gregory, Andrew M. Evens, Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome, British Journal of Haematology, 2012, 156, 2
  2. 2
    M. Extermann, U. Wedding, Comorbidity and geriatric assessment for older patients with hematologic malignancies: A review of the evidence, Journal of Geriatric Oncology, 2012, 3, 1, 49

    CrossRef

  3. 3
    Jane Jijun Liu, Martine Extermann, Comprehensive Geriatric Assessment and Its Clinical Impact in Oncology, Clinics in Geriatric Medicine, 2012, 28, 1, 19

    CrossRef

  4. 4
    Kerri M. Clough-Gorr, Soe Soe Thwin, Andreas E. Stuck, Rebecca A. Silliman, Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment, European Journal of Cancer, 2012, 48, 6, 805

    CrossRef

  5. 5
    Ling-Ping Chen, Shyh-Jer Lin, Ming-Sun Yu, Impact of cutoff age in predicting clinical outcomes of elderly diffuse large B cell lymphoma receiving rituximab or not: A hospital-based study, Journal of Clinical Gerontology and Geriatrics, 2012, 3, 1, 36

    CrossRef

  6. 6
    William A. Wood, Amy P. Abernethy, Sergio A. Giralt, Pretransplantation Assessments and Symptom Profiles: Predicting Transplantation-Related Toxicity and Improving Patient-Centered Outcomes, Biology of Blood and Marrow Transplantation, 2012, 18, 4, 497

    CrossRef

  7. 7
    Eva Walter, Thomas Schmitt,, Sascha Dietrich, Anthony Ho, Mathias Witzens-Harig, Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy, Leukemia & Lymphoma, 2012, 1

    CrossRef

  8. 8
    Fabrice Jardin, Hervé Tilly, Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone: until what age?, Leukemia & Lymphoma, 2012, 53, 4, 521

    CrossRef

  9. 9
    P. Soubeyran, B. Henriques de Figueiredo, I. Soubeyran, C. Mertens, A.L. Cazeau, Therapeutic strategies in elderly and very elderly patients, Best Practice & Research Clinical Haematology, 2012, 25, 1, 91

    CrossRef

  10. 10
    Frédéric Peyrade, Fabrice Jardin, Catherine Thieblemont, Antoine Thyss, Jean-François Emile, Sylvie Castaigne, Bertrand Coiffier, Corinne Haioun, Serge Bologna, Olivier Fitoussi, Gérard Lepeu, Christophe Fruchart, Dominique Bordessoule, Michel Blanc, Richard Delarue, Maud Janvier, Bruno Salles, Marc André, Marion Fournier, Philippe Gaulard, Hervé Tilly, Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial, The Lancet Oncology, 2011, 12, 5, 460

    CrossRef

  11. 11
    P. Soubeyran, C. Bellera, M. Rainfray, Évaluation gériatrique dans les hémopathies lymphoïdes, Oncologie, 2011, 13, 9, 589

    CrossRef

  12. 12
    Yujin Kobayashi, Katsuhiro Miura, Atsuko Hojo, Yoshihiro Hatta, Toshitake Tanaka, Daisuke Kurita, Noriyoshi Iriyama, Sumiko Kobayashi, Jin Takeuchi, Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma, Journal of Cancer Research and Clinical Oncology, 2011, 137, 7, 1079

    CrossRef

  13. 13
    Pierre Soubeyran, Hussein Khaled, Marius MacKenzie, Muriel Debois, Catherine Fortpied, Robrecht de Bock, Joel Ceccaldi, Daphne de Jong, Houchingue Eghbali, Muriel Rainfray, Alain Monnereau, Gilbert Zulian, Ivana Teodorovic, Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly, Journal of Geriatric Oncology, 2011, 2, 1, 36

    CrossRef

  14. 14
    Erika Ramsdale, Sonali Smith, Old versus frail: why it matters in lymphoma, Leukemia & Lymphoma, 2011, 52, 6, 938

    CrossRef

  15. 15
    Jean Klastersky, Andrea Gombos, Aspasia Georgala, Ahmad Awada, Prevention of neutropenia-related events in elderly patients with hematological cancer, Aging Health, 2011, 7, 6, 829

    CrossRef

  16. 16
    Cynthia Owusu, Siran M. Koroukian, Mark Schluchter, Paul Bakaki, Nathan A. Berger, Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments, Journal of Geriatric Oncology, 2011, 2, 2, 121

    CrossRef

  17. 17
    Sumanta K. Pal, Ari Vanderwalde, Arti Hurria, Robert A. Figlin, Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults, Drugs & Aging, 2011, 28, 8, 635

    CrossRef

  18. 18
    Heidi D. Klepin, Ann M. Geiger, Janet A. Tooze, Stephen B. Kritchevsky, Jeff D. Williamson, Leslie R. Ellis, Denise Levitan, Timothy S. Pardee, Scott Isom, Bayard L. Powell, The Feasibility of Inpatient Geriatric Assessment for Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia, Journal of the American Geriatrics Society, 2011, 59, 10
  19. 19
    Mathias Witzens-Harig, Peter Dreger, Autologous transplant of follicular lymphoma in the era of rituximab, Leukemia & Lymphoma, 2010, 51, 6, 967

    CrossRef

  20. 20
    T.H.M. To, M. Okera, J. Prouse, R.J. Prowse, N. Singhal, Infancy of an Australian geriatric oncology program—characteristics of the first 200 patients, Journal of Geriatric Oncology, 2010, 1, 2, 81

    CrossRef

  21. 21
    Pierre Soubeyran, Simone Mathoulin-Pélissier, Anna Josnin, Isabelle Soubeyran, Michèle Kind, Muriel Rainfray, Bernard Hœrni, Overview of aggressive lymphomas in the older adult, Aging Health, 2010, 6, 2, 191

    CrossRef

  22. 22
    Nils Winkelmann, Iver Petersen, Michael Kiehntopf, Hans Joerg Fricke, Andreas Hochhaus, Ulrich Wedding, Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma, Journal of Cancer Research and Clinical Oncology, 2010, 137, 4, 733

    CrossRef